Urolithin A: Evidence, Safety, Dosing Questions, and Access

Urolithin A is a small molecule made by gut microbes from ellagitannins in foods such as pomegranate and some nuts. Human randomized trials have studied it mainly for mitochondrial health, mitophagy-related biomarkers, muscle endurance, exercise performance, and immune-aging markers. It is not FDA-approved to treat disease or extend lifespan. Evidence is promising but not proof of broad anti-aging or disease-treatment benefits 1 2 7.

What it is

Urolithin A is a small molecule and gut-microbial metabolite made when certain gut bacteria process ellagitannins, a type of polyphenol found in foods such as pomegranate. In human research, it is often studied as Urolithin A or as Mitopure, a branded Urolithin A ingredient, with endpoints tied to mitochondrial-health biomarkers and muscle function 1 2.

Urolithin A, Mitopure, and ellagitannin metabolism

Ellagitannins are not the same thing as Urolithin A. They are food polyphenols that some people can convert into urolithins through the gut microbiome; a human clinical trial of pomegranate extract found ellagitannin metabolite formation and stool microbiota changes in healthy volunteers 12.

That gut-microbiome step matters because people differ in their “urolithin metabotype,” meaning they may make different urolithin metabolites after eating similar polyphenol-rich foods. Randomized crossover trials in postmenopausal women have studied polyphenol effects that differed by urolithin A and equol metabotypes, especially for lipid-related and TMAO-related outcomes 9 11.

Evidence grade for Urolithin A

Urolithin A is assigned evidence grade A because the retrieved PubMed set includes multiple human randomized controlled trials, including studies in older adults, middle-aged adults, male athletes, heart-failure patients, and immune-aging research 1 2 3 4 7 13. The grade describes study design and quantity, not whether Urolithin A works for a specific person and not whether it is safe.

Evidence grade rubric

Mechanism of action

Urolithin A is mainly discussed as a mitophagy-related compound. Mitophagy is the cell’s cleanup process for damaged mitochondria, and human trials have measured mitochondrial-health biomarkers rather than proving that Urolithin A makes people live longer 1 2 7.

Mitophagy and mitochondrial-health biomarkers

In older adults, a randomized clinical trial evaluated Urolithin A supplementation for muscle endurance and mitochondrial-health biomarkers 1. In middle-aged adults, another randomized trial studied muscle strength, exercise performance, and mitochondrial-health biomarkers 2.

The key point is that biomarkers are not the same as patient outcomes. A change in a mitochondrial marker may support a biological signal, but it does not prove broader anti-aging, weight-loss, or disease-treatment effects.

Why gut microbiome differences may matter

The gut microbiome may affect how much Urolithin A a person makes from food polyphenols. A randomized trial of multi-species synbiotic supplementation reported increased Urolithin A and butyrate production along with gut microbial diversity and inflammation-related outcomes in healthy adults 5.

Dietary polyphenol trials also add context, but they are not the same as isolated Urolithin A studies. DIRECT PLUS and PREDIMED research studied Mediterranean diet polyphenols, visceral adiposity, DNA methylation-assessed biological age, and cardiovascular-risk signatures; those data should not be treated as proof that isolated Urolithin A produces the same results 6 8 10.

Evidence

Urolithin A has evidence grade A, because two or more human randomized controlled trials are indexed in the supplied PubMed set 13. That is a strong design signal for research maturity, but it does not mean Urolithin A has proven benefits for every outcome people ask about.

A — two or more human randomised controlled trials. B — one human randomised trial, or two or more human clinical trials. C — human research exists, none of it randomised. D — animal or in-vitro research only; no human studies indexed. E — no trial evidence indexed in PubMed. The grade describes the quantity and design of published evidence, not whether the substance works, and not whether it is safe.

Muscle endurance and strength outcomes

The strongest human theme is muscle-related research. Older-adult and middle-aged-adult randomized trials studied Urolithin A for muscle endurance, muscle strength, exercise performance, and mitochondrial-health biomarkers 1 2.

In male athletes doing resistance training, an 8-week randomized, double-blind, placebo-controlled study assessed Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism 4. Individual results vary, and athlete data may not apply to older adults, people with chronic illness, or people using it for general wellness.

Exercise performance and recovery outcomes

Human trials have studied exercise performance in middle-aged adults and athletes, but the study titles and abstracts supplied here do not support turning those results into a guaranteed performance claim 2 4. Performance research is also highly population-specific: trained athletes, older adults, and sedentary adults can respond differently.

Inflammation, oxidative stress, and immune-aging biomarkers

Urolithin A has also been studied for inflammation, oxidative stress, and immune-aging markers. A randomized trial in male athletes assessed inflammation and oxidative stress endpoints, while another randomized placebo-controlled trial studied Urolithin A as a mitophagy inducer in relation to age-related immune decline 4 7.

These are biomarker and function studies, not proof of human lifespan extension. At Chia, we view longevity research through that lens: useful signals are worth studying, but biomarkers should not be sold as guaranteed outcomes.

Heart failure and cardiometabolic context

A randomized, double-blind, crossover, placebo-controlled trial evaluated Urolithin A in heart failure with reduced ejection fraction 3. That is condition-specific clinical research and should not be generalized to healthy people without a clinician’s guidance.

For metabolic health, the evidence is indirect. High-polyphenol Mediterranean diet trials have studied visceral adiposity, DNA methylation-assessed biological age, urinary polyphenol signatures, cardiovascular-disease risk, lipid quality, LDL oxidation, and TMAO-related questions 6 8 9 10 11. Those trials help explain polyphenol biology, but they do not prove that isolated Urolithin A causes the same effects.

What the evidence does not prove

• It does not prove that Urolithin A extends human lifespan.
• It does not prove that Urolithin A causes weight loss.
• It does not prove that Urolithin A treats heart failure, immune decline, inflammation, or oxidative stress for an individual person.
• It does not show that all people make the same amount of Urolithin A from pomegranate-derived polyphenols.
• It does not replace medical treatment, nutrition care, exercise, sleep, or medication review.

How Urolithin A compares with other longevity compounds

People often compare Urolithin A with CoQ10, NAD+, NMN, metformin, and rapamycin. These compounds are not interchangeable: they are studied through different research categories, in different populations, and with different safety questions.

What studies exist

This table is retrieved from PubMed and ClinicalTrials.gov rather than assembled by hand, so it shows what is indexed — including the absences. Last retrieved 2026-09-10.

Reported dosing ranges

Trial dosing is not personal dosing advice. The supplied study records show that Urolithin A has been studied in several human randomized trials, but the provided PubMed records do not include specific dose amounts for most studies 1 2 3 4 7. Do not use a study title, abstract, label, or internet calculator as a personal dosing plan.

Legal status

Our regulatory log holds no confirmed federal action for Urolithin A. That means we have not found one with a primary source — not that none exists.

This section is generated from a dated log of federal actions rather than written by hand, and it is re-checked daily against the Federal Register and FDA sources. Last checked 2026-09-10. See the full legal-status tracker for every compound we follow.

Safety

Urolithin A safety is still best described as incomplete, not settled. The supplied human randomized trials studied defined populations and endpoints, but randomized trials may be too small or too short to detect rare, delayed, or interaction-related harms 1 2 4 7.

What randomized trials can and cannot detect

Randomized trials are helpful because they compare an intervention with a control group. But even a well-run trial may miss rare side effects, risks in people excluded from the study, or problems that appear only after long-term use.

The Urolithin A evidence includes older adults, middle-aged adults, male athletes, and patients with heart failure with reduced ejection fraction 1 2 3 4. That range is useful, but it still does not cover every age, sex, health condition, medication list, or pregnancy status.

Groups who should be especially cautious

• People who are pregnant or breastfeeding should discuss any supplement use with a licensed clinician.
• People with heart failure, kidney disease, liver disease, immune conditions, cancer, or major chronic illness should not assume trial findings apply to them.
• People taking prescription medications should ask about drug-supplement interactions before use.
• People preparing for surgery should tell their care team about supplements, including products marketed for longevity or mitochondrial health.
• Athletes should be careful with product quality, ingredient identity, and sport-governing-body rules.

Supply quality risks

Quality matters because a product label is not the same as proof of identity, purity, or dose. Unregulated supply can raise concerns about ingredient identity, impurities, contamination, and whether the product was made for human use.

This is also why we draw a bright line between medical care and “research use only” vendors. Material sold for research use is not made for patients, and it should not be treated like a clinician-reviewed product.

Interactions

No dedicated Urolithin A drug-interaction study is included in the supplied evidence set. That is not the same as proof of no interactions; it means the interaction evidence provided here is limited.

Supplements, medications, chronic conditions, and surgery

Because Urolithin A is studied in the setting of mitochondrial-health biomarkers, exercise outcomes, immune-aging markers, and cardiometabolic research, it is reasonable to discuss it with a clinician if you take prescription medications or have a chronic condition 1 2 3 7. This is especially important if you take heart, blood pressure, diabetes, immune, cancer, or anticoagulant medications.

If you already use several longevity products, bring the full list to your clinician. Stacking supplements can make side effects harder to trace, even when each product looks low-risk on its own.

How to obtain it legally

Chia does not offer Urolithin A in our current treatment catalog, and we do not prescribe, compound, or ship it. This page is here so you can understand the evidence and have a more informed conversation with a licensed clinician.

A responsible process starts with medical context: your goals, medical history, medications, allergies, pregnancy status, surgery plans, and current supplement list. A prescription, when relevant for any medical treatment, requires a licensed medical evaluation and is never guaranteed.

If you are evaluating any health product, ask about identity testing, purity testing, ingredient amount, lot traceability, and whether the product is intended for human use. Avoid treating “research use only” material as a consumer health product.

For treatments Chia does offer, such as NAD+ and the Foundation Longevity protocol, care is 100% online: a short health questionnaire, review by a licensed US provider, provider-guided dosing where clinically appropriate, and shipment from state-licensed 503A compounding pharmacies. Compounded medications are not FDA-approved.

Keep reading

Metabolic Health

NMN: Evidence, Safety, Dosing and Access

Longevity

Mitochondrial Peptides: What They Are, What the Evidence Shows, and What Is Still Unknown

Longevity

Peptides for Hair Growth: What the Evidence Says